Apo-Gemfibrozil · DIN 01979574 · 300 mg · capsule
General benefit; Health Canada lists this DIN as Cancelled post market since 2024-07-21 — choose a marketed DIN from the same-category list.Discontinued July 21, 2024 · checked November 19, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2024-07-21 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2024-07-21 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Apo-Gemfibrozil · DIN 01979574
Manufacturer: Apotex Inc.; listing date 1996-10-01
Health Canada: Cancelled post market since 2024-07-21 · brand APO-GEMFIBROZIL CAP 300MG USP · ATC C10AB04 GEMFIBROZIL · form Capsule · route Oral · ingredients GEMFIBROZIL 300 MG · company Mission product holdings inc · schedule Prescription
Apo-Gemfibrozil: Formulary list price $0.13 per unit (the source does not state the unit; exact figure $0.1340). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01979574)
Source record
DIN 01979574: Apo-Gemfibrozil
Raw flags: chronicUseMed=Y, sec3=Y
Item: 240600007; group id 305; item number 0667; lccId None; manufacturer id APX
Source form: Cap; strength: 300mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.1340; ministry $0.1340
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01979574
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13840
Interchangeable products
Lopid · DIN 00599026 · not recorded
Teva-Gemfibrozil · DIN 02241704 · $0.1340
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since July 21, 2024 — choose a marketed DIN from the same-category list.